Just found this interesting article, dated August 13, 2018
''Caroline Blackie, O.D., medical director for dry eye at Johnson & Johnson Vision and longtime collaborator of Dr. Korb, has been on the front lines of MGD research. Drs. Korb and Blackie have long argued that doctors of optometry should look for MGD first and the management of most dry eye will follow. ....
Based on her research, Dr. Blackie lists the must-knows for doctors of optometry:
"We should be routinely evaluating gland dysfunction and structure on all patients to take control of ocular surface health," Dr. Blackie says.''
More https://www.aoa.org/news/clinical-ey...erstanding-mgd
''Caroline Blackie, O.D., medical director for dry eye at Johnson & Johnson Vision and longtime collaborator of Dr. Korb, has been on the front lines of MGD research. Drs. Korb and Blackie have long argued that doctors of optometry should look for MGD first and the management of most dry eye will follow. ....
Based on her research, Dr. Blackie lists the must-knows for doctors of optometry:
- MGD is highly prevalent. "It's everywhere-at least 50 percent or more of your patients are going to have this," she says. "That's based on clinical data."
- MGD is best treated early. "Treating it earlier means you have to diagnose it earlier," she says. "Diagnose MGD at the first sign of compromise (inflammation and lid swelling) rather than wait for late-stage symptoms."
- MGD is best attacked by addressing the obstruction of the glands' pores. "Obstruction is the core mechanism of the disease," Dr. Blackie says. "That means evacuating gland content. Squeeze the dickens out of those things."
"We should be routinely evaluating gland dysfunction and structure on all patients to take control of ocular surface health," Dr. Blackie says.''
More https://www.aoa.org/news/clinical-ey...erstanding-mgd
Comment